Seegene to partner with Microsoft for disease-free world

[Courtesy of Seegene]

South Korean molecular diagnostics company Seegene Inc. announced on Wednesday that it will strategically collaborate with the United States’ Microsoft Corp. under its technology-sharing initiative to work towards a disease-free world.

The technology-sharing initiative involves scientists and experts from various countries using Seegene’s Digitalized Development System (SGDDS) on-site to directly develop diagnostic reagents for various human and animal diseases. The Korean company aims to establish joint ventures in each country, partnering with over 100 representative companies worldwide and forming global consortium partnerships.

Seegene signed a partnership with Microsoft in London, the United Kingdom, on Tuesday (local time) to share its syndromic quantitative PCR technologies with global companies and expand participation in international consortiums moving forward.

Seegene will also participate jointly in Microsoft’s annual symposiums and partner events, as well as holding a declaration ceremony in the first half of 2024 for its scientific and technology-sharing business partners to commemorate the shared vision.

SGDDS will integrate Microsoft Azure services, including Azure OpenAI Service, which will be used to process and analyze the vast data generated by the system.

The implementation of the secure and compliant Azure Trusted Research Environment (TRE) will push the boundaries for PCR research, helping ensure both privacy and regulatory adherence, according to the company.

“The strategic collaboration with Microsoft will allow us to have a more structured SG ONeSystem business model,” Seegene chief executive officer and founder Chun Jong-yoon said. “Through our joint efforts, we expect synergetic effects to pave the way for a world free from all diseases.”

For her part, Elena Bonfiglioli, general manager of global health and life sciences at Microsoft, said that “we support Seegene’s vision of realizing a world free from all diseases,” adding that “in addition to working with Seegene on its digital transformation, we will collaborate to discover global partners and to further enhance the healthcare ecosystem.”